Skip to content

Ripasudil 0.4% Eye Drops - TGA Unlicensed Products


HL Pharma has exclusive distribution rights for numerous products and also specialises in sourcing and supply of products that are unlicensed in Australia.

These products may not have TGA registration or maybe an Australian product with supply issues. They are usually supplied under The Special Access Scheme (SAS) or Authorised Prescriber Scheme (APS). Other pathways to supply include Clinical Trial Supply.

For more product information on Ripasudil Eye Drops and similar brands such as; Glantec®  or for further information on sourcing this product or any others, please don't hesitate to contact us.



Ripasudil 0.4% Eye Drops

What is Ripasudil 0.4% Eye Drops?

Ripasudil Eye Drops is a Rho-Kinase inhibitor licensed in Japan.  The ophthalmic solution, Ripasudil 0.4% eye drops, and other brands including Glanatec are not licensed in Australia.

Supply of Ripasudil Eye Drops in Australia

Ripasudil Eye Drops and brands including Glanatec® are often supplied under Special Access Scheme (SAS) C for the treatment of: 

  • Refractory corneal oedema,
  • Refractory glaucoma.

The SAS C system just requires the prescriber to notify The Therapeutic Goods Administration (TGA) of the use of this product

TGA Special Access Scheme

If a prescriber requires many patients to use Ripasudil 0.4% eye drops, or other brands such as Glantec® then they can apply for an Authorised Prescriber approval. 

HL Pharma is a specialist supplier of medicines from overseas. Please contact us for assistance and information. English translated patient leaflets are available as required.


Relevant Links:

Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma

Safety and Efficacy of Long-Term Ripasudil 0.4% Use